Halozyme Therapeutics shares owned by Synovus Financial Corp.
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Synovus Financial Corp.
from 13F filings
Historical chart of Synovus Financial Corp. investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Synovus Financial Corp. consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Synovus Financial Corp.
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $3.8M | 79k | 47.81 |
| 2024-09-30 | $4.6M | 81k | 57.24 |
| 2024-06-30 | $4.6M | 88k | 52.36 |
| 2024-03-31 | $3.6M | 88k | 40.68 |
| 2023-12-31 | $2.9M | 79k | 36.96 |
| 2023-09-30 | $2.2M | 58k | 38.20 |
| 2023-06-30 | $2.2M | 60k | 36.07 |
| 2023-03-31 | $2.1M | 56k | 38.19 |
| 2022-12-31 | $4.5M | 79k | 56.90 |
| 2022-09-30 | $3.0M | 77k | 39.52 |
| 2022-06-30 | $2.3M | 54k | 43.89 |
| 2022-03-31 | $3.1M | 78k | 39.94 |
| 2021-12-31 | $2.8M | 70k | 40.20 |
| 2021-09-30 | $2.5M | 61k | 40.64 |
| 2021-06-30 | $2.3M | 51k | 45.37 |
| 2021-03-31 | $2.1M | 49k | 41.77 |
| 2020-12-31 | $2.2M | 51k | 42.57 |
| 2020-09-30 | $1.6M | 59k | 26.24 |
| 2020-06-30 | $1.3M | 50k | 26.81 |
| 2020-03-31 | $1.1M | 63k | 17.95 |
| 2019-12-31 | $1.1M | 61k | 17.87 |
| 2019-09-30 | $898k | 58k | 15.38 |
| 2019-06-30 | $965k | 56k | 17.22 |
| 2019-03-31 | $862k | 54k | 16.10 |
| 2018-12-31 | $702k | 48k | 14.65 |
| 2018-09-30 | $632k | 35k | 18.08 |
| 2018-06-30 | $560k | 33k | 16.87 |
| 2018-03-31 | $787k | 40k | 19.57 |
| 2017-12-31 | $773k | 38k | 20.29 |
| 2017-09-30 | $664k | 38k | 17.29 |
| 2017-06-30 | $463k | 36k | 12.81 |
| 2017-03-31 | $334k | 26k | 13.07 |
| 2016-12-31 | $191k | 20k | 9.80 |
| 2016-09-30 | $272k | 23k | 12.06 |